Home > News
  print button email button

Friday, June 15, 2012

Team devises stem-cell method for retinal tissue


KOBE — A method to generate multilayered retinal tissue from human embryonic stem cells, developed by a Japanese biological research unit and Sumitomo Chemical Co., has been published in the June 13 edition of the U.S. scientific journal Cell Stem Cell.

It is the first time multilayered retinal tissue has been developed from human ESCs. In the article, the research team at the Riken Center for Developmental Biology and Sumitomo Chemical said, "We demonstrate that an optic cup structure can form by self-organization in human ESC culture."

The method could be applied to regenerative medicine by transplanting the tissue generated to treat conventionally incurable eye diseases such as retinitis pigmentosa, an inherited, degenerative eye disease that causes severe visual impairment and blindness.

"Human ESC-derived neural retina grows into multilayered tissue containing both rods and cones, whereas cone differentiation is rare in mouse ESC culture," the article said.

The researchers developed a method to generate a large amount of such tissue in a short period of time as well as a method that enables en bloc cryopreservation of stratified neural retina of human origin, with useful applications.

Scientist honored overseas


LONDON — Japanese scientist Shinya Yamanaka has received this year's Millennium Technology Prize for his discovery of a new method to produce induced pluripotent stem cells at a ceremony in Helsinki.

He shared the prize with Finland's Linus Torvalds, 42, who developed the Linux open-source computer operating system. They will split the ?1.2 million in prize money, given by Technology Academy Finland, a foundation partially funded by the Finnish government.

We welcome your opinions. Click to send a message to the editor.

The Japan Times

Article 9 of 16 in National news

Previous Next

Back to Top

About us |  Work for us |  Contact us |  Privacy policy |  Link policy |  Registration FAQ
Advertise in japantimes.co.jp.
This site has been optimized for modern browsers. Please make sure that Javascript is enabled in your browser's preferences.
The Japan Times Ltd. All rights reserved.